Comparative bioavailability of two sustained-release theophylline formulations in the dog

Pharmacological Research

Volumn 38, Issue 6, 1998, Pages 481-485

  Mengozzi, Grazia ^a   Intorre, Luigi ^a   Bertini, Simone ^a   Giorgi, Mario ^a   Soldani, Giulio ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Bioequivalence; Dog; Pharmacokinetics; Sustained release formulations; Theophylline

Indexed keywords

AMINOPHYLLINE; THEOPHYLLINE;

ANIMAL EXPERIMENT; ARTICLE; BIOEQUIVALENCE; CONTROLLED STUDY; DOG; DRUG BIOAVAILABILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SUSTAINED RELEASE FORMULATION; THEOPHYLLINE BLOOD LEVEL;

EID: 0032420902     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1006/phrs.1998.0394     Document Type: Article

References (14)

1. 1. Davis LE. Clinical pharmacology of the respiratory system. In Proceedings of the Illinois Veterinary Respiratory Symposium, College of Veterinary Medicine, University of Illinois, Urbana, 1978: 46-57.
2. 2. Alberola J, Perez Y, Puigdemont A, Arboix M. Effect of age on theophylline pharmacokinetics in dogs. Am J Vet Res 1993; 54: 1112-15.
3. 3. Nosaka H, Takagi K, Hasegawa T, Ogura Y, Mizukami Y, Satake T. Pharmacokinetics of theophylline in beagle dogs and asthmatic patients after multiple oral doses of sustained-release theophylline tablet formulation. Int J Clin Pharmacol Ther Toxicol 1986; 24: 528-35.
4. 4. Hendeles L, Weinberger M. Selection of a slow-release theophylline product. J Allergy Clin Immunol 1986; 78: 743-51.
5. 5. Koritz GD, McKiernan BC, Neff-Davis CA, Munsiff IJ. Bioavailability of four slow-release theophylline formulations in the Beagle dog. J Vet Pharmacol Ther 1986; 9: 293-302.
6. 6. Hendles L, Iafrate RP, Weinberger M. A clinical and pharmacokinetic basis for the selection and use of slow release theophylline products. Clin Pharmacokinet 1984; 9: 95-135.
7. 7. Dye JA, McKiernan BC, Jones SD, Neff-Davis GA, Koritz GD. Sustained-release theophylline pharmacokinetics in the cat. J Vet Pharmacol Ther 1989; 12: 135-40.
8. 8. Yamakoa K, Nakagawa T, Uno T. Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations. J Pharmacokinet Biopharm 1978; 6: 165-75.
9. 9. Gibaldi M, Perrier D. Pharmacokinetics. Marcel Dekker, Inc., New York, 1982.
10. 10. Errecalde JO, Button C, Baggot JD, Mulders SG. Pharmacokinetics and bioavailability of theophylline in horses. J Vet Pharmacol Ther 1984; 7: 255-63.
11. 11. Hussein Z, Bialer M, Friedman M, Raz I. Pharmacokinetic analysis of sustained-release dosage forms of theophylline in humans: comparison of single and multiple dose studies. Biopharm Drug Dispos 1987; 8: 427-35.
12. 12. McKiernan BC, Gonzales MA, Neff-Davis CA. Sustained-release theophylline pharmacokinetics in the dog. Proceedings of the Second Annual Forum and Twelfth Annual Scientific Program of the American College of Veterinary Internal Medicine, May 17-20, Washington, D.C., 1984: 52.
13. 13. Ritschel WA. Bioavailability/bioequivalence of modified release drug delivery system: which pharmacokinetic parameters to determine, single or multiple dose studies, pretests, conditions and other aspects. Method Find Exp Clin Pharmacol 1992; 14: 469-82.
14. 14. McKiernan BC, Koritz GD, Davis L, Neff-Davis CA, Pheris D. Pharmacokinetic studies of theophylline in cats. J Vet Pharmacol Ther 1983; 6: 99-104.